nitrous oxide

Small moleculeapproved

Approved

Jun 16, 2013

Nitrous oxide (N2O, laughing gas) was first discovered by the English scientist Joseph Priestly and has been used for more than 150 years. It has remained one of the most widely used anesthetics in both dental and medical applications. This small and simple inorganic chemical molecule has indisputable effects of analgesia, anxiolysis, and anesthesia that are of great clinical interest. As a general anesthetic, it is very weak and is generally not used as a single agent. It may be used as a carrier gas with oxygen in combination with more potent general inhalational gases for surgical anesthesia. In dentistry, it is commonly used as a single agent (with oxygen) for partial sedation, most commonly in pediatric dental populations. Findings to date indicate that the analgesic effect of N2O is opioid in nature, and, like morphine, may involve a myriad of neuromodulators in the spinal cord. The anxiolytic effect of N2O, on the other hand, resembles that of benzodiazepines and may be initiated at selected subunits of the gamma-aminobutyric acid type A (GABA(A)) receptor. Similarly, the anesthetic effect of N2O may involve actions at GABA(A) receptors and possibly at N-methyl-D-aspartate receptors as well. — NCATS

Clinical trial activity

179 trials · 157 clinical orgs · 6 marketing orgs

Phase 1
17
Phase 2
51
Phase 3
24
Phase 4
44

Earliest trial started Sep 1, 1993 (NCT00000249)

Timeline

1790s

  1. Jun 1, 1794

    Evidence of US Marketing

1990s

  1. Jan 1, 1993

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 1998

    Earliest Phase 3 Sponsor(trial)

2000s

  1. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jun 16, 2013

    Earliest FDA Approval

  2. Jun 16, 2013

    Air Liquide — NDA Secondary Org

  3. Sep 3, 2013

    Nitrous Oxide Corp — First NDA Organization

  4. Sep 3, 2013

    Airgas Usa Llc — NDA Secondary Org

  5. Sep 3, 2013

    Nitrous Oxide Corp — NDA Organization

  6. Sep 6, 2013

    Airgas Usa Llc — Marketing Organization

  7. Nov 25, 2014

    Strata Medical Innovations — NDA Secondary Org

  8. Jan 9, 2017

    Matheson Tri-Gas Inc — NDA Secondary Org

  9. Mar 6, 2017

    Praxair — NDA Secondary Org

Indications

Approved for

Studied for

Mechanism of action

Approval history

  • approvedJun 16, 2013
  • approvedJun 1, 1794

Chemistry & pharmacology

Loading structure…

SMILES

[O-][N+]#N
Mol. weight
44.0128 g/mol
Lipinski Ro5
Pass
Rule of 3
Yes
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • dinitrogen monoxide
  • dinitrogen oxide
  • entonox
  • entonox
  • nitrious oxide
  • nitrious oxide
  • nitrious oxide
  • nitrous oxide
  • nitrous oxide
  • nitrous oxide
  • nitrous oxide
  • nitrous oxide
  • nitrous oxide
  • nitrous oxide
  • nitrous oxide
  • nitrous oxide
  • nitrous oxide
  • nitrous oxide

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07262008Phase 3Feb 1, 2026Canadian Institutes of Health Research (CIHR), Unity Health Toronto, University of Toronto
NCT07245628Early Phase 1 (Phase 1)Oct 20, 2025Harvard University
NCT07118644Phase 3Sep 1, 2025University of Western Brittany
NCT06702631Early Phase 1 (Phase 1)Feb 1, 2025National Institute of General Medical Sciences (NIGMS), University of Pittsburgh
NCT06557642N/AJul 10, 2024University of Oxford
NCT06430489Phase 2Jun 30, 2024University Hospital, Tours
NCT06498908Phase 3May 15, 2024Maimonides Medical Center
NCT05890898N/ASep 19, 2023Geisinger Clinic
NCT05710887Phase 2Jul 1, 2023University of Chicago
NCT05178849N/AJun 1, 2023University of Rennes
NCT05895383Phase 4May 24, 2023Harvard University
NCT05883332Phase 4Jan 10, 2023Harvard University
NCT05579288Early Phase 1 (Phase 1)Dec 31, 2022Tel Aviv University
NCT05388942N/ANov 30, 2022University of Reims
NCT05383495Phase 3Oct 1, 2022University of Western Ontario
NCT06118567Phase 2Sep 6, 2022National Institute of Mental Health (NIMH), Ohio State University
NCT05396144Phase 4Aug 31, 2022Stanford University
NCT05510141N/AAug 24, 2022University of Bern
NCT05430750Phase 4Jun 29, 2022Sir Ganga Ram Hospital
NCT05167331N/AFeb 28, 2022University of Strasbourg
Showing 20 of 179 trials
Page 1 / 9

Organizations

Research & Development (157)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of ChicagoAcademic/Hospital191921993
National Institute on Drug Abuse (NIDA)Government16021993
Washington University in St. LouisAcademic/Hospital8842008
Air LiquideFor profit7642000
Harvard UniversityAcademic/Hospital6642014
Monash UniversityAcademic/Hospital6322003
Yeshiva UniversityAcademic/Hospital5422013
Stanford UniversityAcademic/Hospital4432018
The Alfred HospitalAcademic/Hospital4022003
University of New MexicoAcademic/Hospital4412012
University of ParisAcademic/Hospital4322008
University of ToulouseAcademic/Hospital4432010
Ohio State UniversityAcademic/Hospital3322012
Society of Family PlanningAcademic/Hospital3012013
Tel Aviv UniversityAcademic/Hospital3322014
University Clermont AuvergneAcademic/Hospital3312014
University of Colorado, DenverAcademic/Hospital3122016
University of LyonAcademic/Hospital3232006
University of RochesterAcademic/Hospital3321998
University of TorontoAcademic/Hospital3332015
157 organizations
Page 1 / 8

Marketing (7)

OrganizationOrg typeRelationshipDate
Air LiquideFor profitNDA2Jun 16, 2013
Airgas Usa LlcFor profitNDA2Sep 3, 2013
Airgas Usa LlcFor profitMKTGSep 6, 2013
Matheson Tri-Gas IncFor profitNDA2Jan 9, 2017
Nitrous Oxide CorpFor profitNDASep 3, 2013
PraxairFor profitNDA2Mar 6, 2017
Strata Medical InnovationsFor profitNDA2Nov 25, 2014